Spherix’s coverage of the polycystic kidney disease market leverages quarterly trackers with patient chart audits to provide insights into evolving treatment trends for ADPKD, as well as ARPKD, patients. Research covers Issues such as current treatment methods, best practices in disease tracking and imaging, and potential for new pipeline products.
Trending market evolution
Polycystic Kidney Disease (US) - quarterly, n=100
Exploring the patient journey
Polycystic Kidney Disease (US) - annual, n=1,000 patient charts